EXACT SCIENCES CORP — Regulatory Filings 2013

Apr 18, 2013

*UNITED STATES SECURITIES AND EXCHANGE COMMISSION*

*Washington, D.C. 20549*

*FORM 8-K*

*CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934*

Date of Report (Date of earliest event reported): April 18, 2013

*EXACT SCIENCES CORPORATION*

(Exact Name of Registrant as Specified in Charter)

Delaware	000-32179	02-0478229
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

*441 Charmany Drive Madison, WI 53719*

(Address of Principal Executive Offices)(Zip Code)

Registrant’s telephone number, including area code: (608) 284-5700

*Not Applicable*

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

SEQ.=1,FOLIO='',FILE='C:\JMS\C901359\13-6201-2\task5969596\6201-2-ba.htm',USER='C901359',CD='Apr 18 09:04 2013'

*7.01. Regulation FD Disclosure.*

On April 18, 2013, Exact Sciences Corporation (the “Company”) issued a press release reporting preliminary top-line data from the DeeP-C clinical trial for the Company’s Cologuard colorectal cancer screening test.

A copy of the press release is furnished as Exhibit 99 to this Current Report and is incorporated herein by reference.

*9.01. Financial Statements and Exhibits.*

*Exhibits*

The exhibits required to be filed as a part of this Current Report on Form 8-K are listed in the Exhibit Index attached hereto and incorporated herein by reference.

2

SEQ.=1,FOLIO='2',FILE='C:\JMS\C901359\13-6201-2\task5969596\6201-2-ba.htm',USER='C901359',CD='Apr 18 09:04 2013'

*SIGNATURES*

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

/s/ Maneesh Arora
Maneesh Arora
Chief Operating Officer

3

SEQ.=1,FOLIO='3',FILE='C:\JMS\C901359\13-6201-2\task5969596\6201-2-ba.htm',USER='C901359',CD='Apr 18 09:04 2013'

*EXHIBIT INDEX*

Exhibit No.	Exhibit Description
99	Press release, dated April 18, 2013, issued by Exact Sciences Corporation, furnished herewith

4

SEQ.=1,FOLIO='4',FILE='C:\JMS\C901359\13-6201-2\task5969596\6201-2-ba.htm',USER='C901359',CD='Apr 18 09:04 2013'